Introduction The past two decades have been marked by three epidemics linked to
emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological …

Abstract Introduction Coronavirus disease-19 (COVID-19) pandemic continues to grow all
over the world. Several studies have been performed, focusing on understanding the acute …

Context Autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome) can be
seen as a postvaccination phenomenon that occurs after exposure to adjuvants in vaccines …

Patients with long COVID suffer from many neurological manifestations that persist for 3
months following infection by SARS-CoV-2. Autonomic dysfunction (AD) or dysautonomia is …

Abstract Coronavirus disease 2019 (COVID-19), which resulted from the pandemic outbreak
of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a massive …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the
coronavirus disease 2019 (COVID-19) pandemic. In addition to severe respiratory …

In December 2019, a novel coronavirus known as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) emerged in Wuhan, the capital of Hubei, China. The virus …

The SARS-CoV-2 virus gains entry to cells by binding to angiotensin-converting enzyme 2
(ACE2). Since circumventricular organs and parts of the hypothalamus lack a blood–brain …

Abstract The coronavirus disease 2019 (COVID-19) came under the attention of the
international medical community when China first notified the World Health Organization of a …

Severe acute respiratory coronavirus 2 (SARS-CoV-2) interacts with the host cells through
its spike protein by binding to the membrane enzyme angiotensin-converting enzyme 2 …